|
Mr. Berg joins Oscient from Kos Pharmaceuticals where he served as Vice President of Marketing and directed all marketing activities for in-line and new products, including strategic and tactical business planning and execution, market research and lifecycle management. Leading up to Abbott’s acquisition of Kos, Mr. Berg also held concurrent responsibility as Vice President, Sales for the Eastern Division. Prior to his promotion to Vice President of Marketing, Mr. Berg was Executive Director of Marketing at Kos, where he directed brand strategy for the Kos flagship product, NIASPAN. Mr. Berg joined Kos from GlaxoSmithKline where he was the Senior Product Manager for AVANDIA. Previously, Mr. Berg held positions of increasing responsibility in sales, disease management and marketing at Schering-Plough and was responsible for making IMDUR the highest prescribed long-acting nitrate product worldwide with sales in excess of $200 million. Mr. Berg received a B.S. in Marketing from the University of Maryland. | 